CANCER STUDIES AND MOLECULAR MEDICINE ISSN 2377-1518
Editorial *
Corresponding author
Francis V. James, MD
Uro Oncology Clinic Regional Cancer Center Trivandrum 695011, India Tel. +919847189270 E-mail:
[email protected]
http://dx.doi.org/10.17140/CSMMOJ-3-e003
Open Journal
Prostate Cancer Trends in Developing Countries Aleyamma Mathew, PhD; Francis V. James, MD* Regional Cancer Center, Trivandrum 695011, India
Volume 3 : Issue 1 Article Ref. #: 1000CSMMOJ3e003
Article History Received: September 7th, 2016 Accepted: September 8th, 2016 Published: September 14th, 2016
Citation
Mathew A, James FV. Prostate cancer trends in developing countries. Cancer Stud Mol Med Open J. 2016; 3(1): e1-e2. doi: 10.17140/CSMMOJ3-e003
Prostate cancer is the commonest cancer in USA and most European Countries and is the 2nd commonest cancer among males globally. An estimated 1.1 million men worldwide were diagnosed with prostate cancer in 2012, accounting for 15% of the cancers diagnosed in men. Incidence of this disease varies more than 25-fold worldwide; the rates are highest in Australia/New Zealand and Northern America (ASR 111.6 and 97.2 per 100,000 respectively), and in Western and Northern Europe, because the practice of prostate specific antigen (PSA) testing and subsequent biopsy has become widespread in those regions.1 Low incidence rates (